Institut Català de la Salut
[Carrion-Alvarez L] HPB Unit, General Surgery Department, Fuenlabrada University Hospital, Madrid, Spain. [Primavesi F] Department of Visceral, Transplant and Thoracic Surgery, Medical University of Innsbruck, Innsbruck, Austria. [Søreide K] Department of Gastrointestinal Surgery, HPB Unit, Stavanger University Hospital, Stavanger, Norway. Department of Clinical Medicine, University of Bergen, Bergen, Norway. Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. [Sochorova D] Department of Surgery, Tomas Bata Hospital Zlin, Czech Republic. [Diaz-Nieto R] Hepatobiliary Surgery Unit, Liverpool University Hospital, Liverpool, UK. [Dopazo C] Servei de Cirurgia Hepatobiliopancreàtica i Trasplantaments, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain
Vall d'Hebron Barcelona Hospital Campus
2025-04-04T06:18:07Z
2025-04-04T06:18:07Z
2025-06
Colorectal cancer; Liver metastases; Surgical oncology
Cáncer colorrectal; Metástasis hepáticas; Oncología quirúrgica
Càncer colorectal; Metàstasis hepàtiques; Oncologia quirúrgica
Colorectal liver metastases (CRLM) are a major indication for liver surgery in Europe, highlighting the need for standardized knowledge and training in surgical oncology. The European Society of Surgical Oncology (ESSO) has updated its core curriculum to provide a structured framework for education. Previous publications have addressed pancreatic, hepatocellular, and biliary tract cancers to support candidates preparing for the European Board of Surgery Qualification (EBSQ) exams in Surgical Oncology and Hepato-Pancreato-Biliary Surgery. However, a dedicated guide for CRLM remains absent. This article aims to fill that gap by offering a structured reference on CRLM, covering epidemiology, staging, genetics, and diagnosis of metastatic colorectal cancer. It also outlines multidisciplinary treatment strategies, including systemic, surgical, interventional, and palliative approaches. A structured literature review was conducted using PubMed to identify the most updated (inter)national management guidelines, prioritizing recent multicentre studies, systematic reviews, and meta-analyses published from January 2020 to January 2025. By bridging the gap between the ESSO core curriculum and detailed subspecialty training, this guide provides an essential resource for hepatobiliary surgeons and surgical oncologists. It serves as a valuable tool for those preparing for board examinations while promoting a standardized approach to CRLM education and management across Europe.
Article
Versió publicada
Anglès
Metàstasi; Recte - Càncer; Còlon - Càncer; Fetge - Càncer - Cirurgia; DISEASES::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Intestinal Neoplasms::Colorectal Neoplasms; DISEASES::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Liver Neoplasms; Other subheadings::Other subheadings::Other subheadings::/surgery; DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Metastasis; ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias gastrointestinales::neoplasias intestinales::neoplasias colorrectales; ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias hepáticas; Otros calificadores::Otros calificadores::Otros calificadores::/cirugía; ENFERMEDADES::neoplasias::procesos neoplásicos::metástasis neoplásica
Elsevier
European Journal of Surgical Oncology;51(6)
https://doi.org/10.1016/j.ejso.2025.109728
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
Articles científics - VHIR [1655]